Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
about
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.IL-6 as a druggable target in psoriasis: focus on pustular variants.Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.Immunohistochemical Comparison of IL-36 and the IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis[Pustular psoriasis].The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.Alitretinoin therapy for palmoplantar pustulosis.Scanning the Immunopathogenesis of Psoriasis.Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study.Pustular psoriasis: pathophysiology and current treatment perspectives.A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial
P2860
Q30251512-E053836A-9251-4FA7-8905-0617E2E5278CQ34003280-92930D8E-DFBE-42C1-9C43-F525439F2405Q36010791-FFC259E0-BF01-4C75-9F27-00CC2ECCB562Q37144182-F443BC8E-99E9-4412-98BB-8F61E57C7718Q40653524-26BE7E78-C470-4A4D-A34A-66EBA0E40B3CQ46546377-D33AC628-AE54-48B8-A76D-0E0328006C34Q48230196-E5849C86-05D2-46BE-A9C1-F97AE72A793AQ48278167-1FE28A15-5B68-427E-B05E-A73258B79B69Q50126864-457D43BD-F6D0-4217-914E-211AAF9653FFQ53756627-DD71C191-9ADE-4E58-8D9F-7245B35019E0Q55401560-43EF5095-B912-405E-9660-77D9FDFB184AQ58695016-A22ECB35-F743-469C-8FFA-D01B106BA9C4
P2860
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Increased expression of IL-17A ...... a randomised controlled trial.
@en
Increased expression of IL-17A ...... in patients with palmo-plantar
@nl
type
label
Increased expression of IL-17A ...... a randomised controlled trial.
@en
Increased expression of IL-17A ...... in patients with palmo-plantar
@nl
prefLabel
Increased expression of IL-17A ...... a randomised controlled trial.
@en
Increased expression of IL-17A ...... in patients with palmo-plantar
@nl
P2093
P2860
P356
P1476
Increased expression of IL-17A ...... a randomised controlled trial.
@en
P2093
J Fuentes-Duculan
J G Krueger
R Bissonnette
R G Langley
P2860
P304
P356
10.1111/JDV.12272
P577
2013-09-24T00:00:00Z